Le Lézard
Classified in: Health
Subject: CHI


National distribution network will get formula to shelves around the country

PARSIPPANY, N.J., July 1, 2022 /PRNewswire/ -- Reckitt is proud to provide the largest delivery of infant formula to the United States on three UPS flights from our world-class facility in Tuas, Singapore, facilitated by the White House's Operation Fly Formula initiative. With Reckitt's contribution of over 418,000 pounds of infant formula base powder, which equates to approximately 6 million 8-oz servings, this is a significant step toward bringing the U.S. infant formula shortage to an end. Our infant formula powder will be finished and packaged in the United States as Enfamil, a brand that U.S. consumers have known and trusted for generations, and which is the No. 1 recommended brand by pediatricians. These Enfamil products are already part of an extensive nationwide distribution network that reaches retail shelves across America quickly and efficiently and are also approved as WIC-eligible, to meet the needs of every family searching for infant formula.

Between now and November, Reckitt will import the equivalent of 66 million 8-oz servings of Enfamil formula, the biggest contribution from an existing US brand. Our manufacturing facilities are operating 24/7, and we're continually looking for more ways to increase supply, while ensuring the highest levels of safety and quality. Reckitt is thankful for the support from the White House, the Food and Drug Administration (FDA) and U.S. Department of Health and Human Services (HHS), our supply chain partners and employees globally, who have stepped up to enable us to take every measure we can to end this shortage as quickly as possible.

About Reckitt:

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more. Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always. We are a diverse global team of more than 43,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society.  Find out more, or get in touch with us at www.reckitt.com

About Mead Johnson Nutrition:

Mead Johnson Nutrition was acquired by Reckitt in 2017, merging the two company's commitments to innovation and science to continue fueling advancements in pediatric nutrition. Today, the nutrition business continues to drive innovation from its Evansville, IN site and is trusted by parents and healthcare professionals all over the world to support developing minds and bodies. We're committed to ensuring that every mom and every baby a healthy start.

About Enfamil 

Enfamil's full product portfolio is formulated to provide optimal nutrition for infants and children through every stage of development. Their dedication to science and innovation remains vital to both their product portfolio and mission by using leading-edge technologies, a highly specialized team, and expert collaborations to benefit pediatric populations around the world. Today, the Enfamil brand is trusted by parents and healthcare professionals through their passion for innovation and delivering high quality products.

* Reckitt is the trading name of the Reckitt Benckiser group of companies

SOURCE Reckitt

These press releases may also interest you

at 21:05
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service CRDMO backed by Advent International, and X-Chem, a DEL technology pioneer in small molecule drug discovery, jointly announced the launch of DNA Encoded Compound...

at 20:30
On August 1, 2022, U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food and Drug Administration ("FDA"). Malignant glioma has...

at 20:10
--ASC61 is an in-house developed oral PD-L1 small molecule inhibitor prodrug that showed significant antitumor efficacy in preclinical studies as a single agent in multiple animal models --ASC61-A treatment induced secretion of IFN? in a...

at 20:05
GEMSTONE-301 study result was presented at IASLC 2022 World Conference on Lung Cancer. In addition, the leading Principal Investigator Professor Yi-Long Wu was invited to highlight key data in a press conferenceIn the final progression-free survival...

at 20:00
NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan's Food and Drug Administration (TFDA) in July 2022, and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022....

at 20:00
Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the appointment of...

News published on 1 july 2022 at 17:39 and distributed by: